XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock Class A
Common Stock
Common Stock Class A
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     181,945,771      
Beginning balance at Dec. 31, 2023 $ 9,732,552   $ 182 $ 14,797,723 $ 619 $ (5,065,972)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (55,349)         (55,349)
Exercises of vested stock options (in shares)     43,835      
Exercises of vested stock options 421     421    
Vesting of restricted stock units (in shares)     1,615,930      
Vesting of restricted stock units 0   $ 1 (1)    
Value of equity awards withheld for tax liability (in shares)     (26,757)      
Value of equity awards withheld for tax liability (1,918)     (1,918)    
Shares of Class A common stock issued and donated to charity (in shares)     22,102      
Shares of Class A common stock issued and donated to charity 1,295     1,295    
Shares returned from escrow (in shares)     (696)      
Shares returned from escrow (192)     (192)    
Unrealized gain (loss) on marketable securities (5,193)       (5,193)  
Repurchases of shares of Class A common stock including related costs (in shares)     (6,128,298)      
Repurchases of shares of Class A common stock including related costs (387,028)   $ (6)     (387,022)
Net change in market value of effective foreign currency forward exchange contracts (4,505)       (4,505)  
Share of other comprehensive (loss) income from equity method investment 4,138       4,138  
Stock-based compensation 163,509     163,509    
Ending balance (in shares) at Mar. 31, 2024     177,471,887      
Ending balance at Mar. 31, 2024 9,447,730   $ 177 14,960,837 (4,941) (5,508,343)
Beginning balance (in shares) at Dec. 31, 2024   152,610,697 152,610,697      
Beginning balance at Dec. 31, 2024 7,952,966   $ 153 15,476,124 (1,301) (7,522,010)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 20,017         20,017
Exercises of vested stock options (in shares)     131,515      
Exercises of vested stock options 2,766     2,766    
Vesting of restricted stock units (in shares)     1,712,644      
Vesting of restricted stock units 0   $ 2 (2)    
Value of equity awards withheld for tax liability (in shares)     (423)      
Value of equity awards withheld for tax liability (53)     (53)    
Shares of Class A common stock issued and donated to charity (in shares)     22,102      
Shares of Class A common stock issued and donated to charity 2,776     2,776    
Unrealized gain (loss) on marketable securities 5,058       5,058  
Repurchases of shares of Class A common stock including related costs (in shares)     (1,222,193)      
Repurchases of shares of Class A common stock including related costs (129,774)   $ (2)     (129,772)
Net change in market value of effective foreign currency forward exchange contracts 8,386       8,386  
Share of other comprehensive (loss) income from equity method investment (1,785)       (1,785)  
Stock-based compensation 143,934     143,934    
Ending balance (in shares) at Mar. 31, 2025   153,254,342 153,254,342      
Ending balance at Mar. 31, 2025 $ 8,004,291   $ 153 $ 15,625,545 $ 10,358 $ (7,631,765)